Ptc Therapeutics (PTCT) Net Margin (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Net Margin of 23.16% for Q2 2026, up 5941.0% year-over-year from 0.38% in Q2 2025, and up 2347.16% quarter-over-quarter from 1.03% in Q1 2026.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Net Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Net Margin history runs 15 years deep, the most recent figure standing at 23.16% for Q2 2026.
- In Q2 2026, Net Margin rose 5941.0% year-over-year to 23.16%; the TTM figure through Jun 2026 stood at 37.92% (up 227.0% YoY), while the FY2025 annual figure was 58.16%, up 10319.0% from the prior year.
- Net Margin for Q2 2026 stood at 23.16%, up from 1.03% in the prior quarter.
- The five-year high for Net Margin was 173.62% in Q4 2025, with the low at 102.08% in Q4 2022.
- The 5-year median for Net Margin is 50.35% (2022), against an average of 28.94%.
- The sharpest annual moves came in 2025 and 2026: Net Margin jumped 20453 bps in 2025, then tumbled 7471 bps in 2026.
- Ptc Therapeutics' Net Margin stood at 102.08% in 2022, then surged by 50 bps to 50.74% in 2023, then surged by 39 bps to 30.91% in 2024, then surged by 662 bps to 173.62% in 2025, then plunged by 87 bps to 23.16% in 2026.
- Business Quant data shows PTCT's Net Margin at 23.16% in Q2 2026, 1.03% in Q1 2026, and 173.62% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Ptc Therapeutics | 5.78 Bn | 3.55 Bn | 340.60 Mn | 23.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.16% |
| Mar 31, 2026 | -1.03% |
| Dec 31, 2025 | 173.62% |
| Sep 30, 2025 | 7.53% |
| Jun 30, 2025 | -36.25% |
| Mar 31, 2025 | 73.68% |
| Dec 31, 2024 | -30.91% |
| Sep 30, 2024 | -54.20% |
| Jun 30, 2024 | -53.12% |
| Mar 31, 2024 | -43.58% |
| Dec 31, 2023 | -50.74% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -93.02% |
| Mar 31, 2023 | -63.05% |
| Dec 31, 2022 | -102.08% |
| Sep 30, 2022 | -50.35% |
| Jun 30, 2022 | -91.88% |
| Mar 31, 2022 | -85.20% |
| Dec 31, 2021 | -86.71% |
| Sep 30, 2021 | -96.31% |